Journals / Turkish Thoracic Journal / 2021 / Cilt: 22 - Sayı: 1

Decreasing Rate of Unknown Bronchiectasis Etiology: Evaluation of 319 Adult Patients with Bronchiectasis

Pages
18–23
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, with improvements in diagnostic tests and procedures, the rate of unknown etiologies has dropped from ≥50% to 12.9%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Bronchiectasis can have several causes, but there are only a limited number of studies about the prevalence of these causes.
📊
Key Findings & Data:This study aimed to identify etiologies in adult patients with bronchiectasis.MATERIAL AND METHODS: Between January 1996 and June 2015, data from 319 patients admitted to a specialized bronchiectasis clinic were analyzed.
💡
Conclusion & Impact:However, with improvements in diagnostic tests and procedures, the rate of unknown etiologies has dropped from ≥50% to 12.9%.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

OBJECTIVE: Bronchiectasis can have several causes, but there are only a limited number of studies about the prevalence of these causes. Most of the studies in adults are from previous years. This study aimed to identify etiologies in adult patients with bronchiectasis.MATERIAL AND METHODS: Between January 1996 and June 2015, data from 319 patients admitted to a specialized bronchiectasis clinic were analyzed. Diagnoses were confirmed using high-resolution or multislice computed tomography and were retrospectively evaluated.RESULTS: Of the 319 patients, 187 (58.6%) were women and 132 (41.4%) were men. The mean age was 49.0±17.4 (range 15–83) years. The mean duration of illness was 19.5±14.9 years. There were several common etiologies: (1) post-infections (215; 67.5%, 70 of the 215 patients had tuberculosis); (2) obstructive lung diseases (28, 8.8%); (3) defects in mucociliary clearance (13, 4.2%); (4) connective tissue diseases (8, 2.4%); (5) immunodeficiency (5, 1.5%); (6) structural lung conditions (1, 0.3%); and (7) obstruction of a single bronchus (1, 0.3%). No causes could be established in 41 (12.9%) patients. CONCLUSION: Despite developments in antibiotic therapy and vaccination programs, the most common etiology for bronchiectasis is post-infectious conditions as observed in previous years. However, with improvements in diagnostic tests and procedures, the rate of unknown etiologies has dropped from ≥50% to 12.9%.

🔖

Cite This Article

BÖREKÇİ, Ş., MÜSELLİM, B. (2021). Decreasing Rate of Unknown Bronchiectasis Etiology: Evaluation of 319 Adult Patients with Bronchiectasis. Turkish Thoracic Journal, Cilt: 22 - Sayı: 1, 18–23. https://ajindex.com/articles/417262

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Bilton D. Update on non-cystic fibrosis bronchiectasis. Curr Opin Pulm Med 2008
  2. [Crossref] 2. Goeminne P, Dupont L. Non-cystic fibrosis bronchiectasis: diagnosis and management in 21st century. Postgrad Med J 2010
  3. [Crossref] 3. Li AM, Sonnappa S, Lex C, et al. Non-CF bronchiectasis: Does knowing the aetiology lead to changes in management? Eur Respir J 2005
  4. [Crossref] 4. Roguin A. Rene Theophile Hyacinthe Laënnec (1781-1826): the man behind the stethoscope. Clin Med Res 2006
  5. [Crossref] 5. Drain M, Elborn JS. Assessment and investigation of adults with bronchiectasis. Eur Respir Mon 2011
  6. [Crossref] 6. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med 2000
  7. 162(4 Pt 1):1277-84. [Crossref] 7. Scala R, Aronne D, Palumbo U, et al. Prevalence, age distribution and aetiology of bronchiectasis: a retrospective study on 144 symptomatic patients. Monaldi Arch Chest Dis 2000
  8. Bilton D, Jones AL. Bronchiectasis: epidemiology and causes. Eur Respir Mon 2011
  9. [Crossref] 9. Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med 2007
  10. [Crossref] 10. Dimakou K, Triantafillidou C, Toumbis M, et al. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir Med 2016
  11. [Crossref] 11. Hill AT, Sullivan AL, Chalmers JD et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax 2019
  12. 74(Suppl 1):1-69. [Crossref] 12. Qi Q, Wang W, Li T, et al. Aetiology and clinical characteristics of patients with bronchiectasis in a Chinese Han population: A prospective study. Respirology 2015
  13. [Crossref] 13. Reid LM. Reduction in bronchial subdivision in bronchiectasis. Thorax. 1950
  14. [Crossref] 14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005
  15. Rutland J, Griffin W, Cole P. Nasal brushing and measurement of ciliary beat frequency. An in vitro method for evaluating pharmacologic effects on human cilia. Chest 1981
  16. 80(6 Suppl):865-7. [Crossref] 16. Rutland J, Dewar A, Cox T, Cole P, et al. Nasal brushing for the study of ciliary ultrastructure. J Clin Pathol 1982
  17. [Crossref] 17. Baumer JH. Evidence based guidelines for the performance of the sweat test for the investigation of cystic fibrosis in th